Literature DB >> 12097555

Addition of exogenous protease facilitates reovirus infection in many restrictive cells.

Joseph W Golden1, Jessica Linke, Stephen Schmechel, Kara Thoemke, Leslie A Schiff.   

Abstract

Virion uncoating is a critical step in the life cycle of mammalian orthoreoviruses. In cell culture, and probably in extraintestinal tissues in vivo, reovirus virions undergo partial proteolysis within endosomal or/or lysosomal compartments. This process converts the virion into a form referred to as an intermediate subvirion particle (ISVP). In natural enteric reovirus infections, proteolytic uncoating takes place extracellularly within the intestinal lumen. The resultant proteolyzed particles, unlike intact virions, have the capacity to penetrate cell membranes and thereby gain access to cytoplasmic components required for viral gene expression. We hypothesized that the capacity of reovirus outer capsid proteins to be proteolyzed is a determinant of cellular host range. To investigate this hypothesis, we asked if the addition of protease to cell culture medium would expand the range of cultured mammalian cell lines that can be productively infected by reoviruses. We identified many transformed and nontransformed cell lines, as well as primary cells, that restrict viral infection. In several of these restrictive cells, virion uncoating is inefficient or blocked. Addition of proteases to the cell culture medium generates ISVP-like particles and promotes viral growth in nearly all cell lines tested. Interestingly, we found that some cell lines that restrict reovirus uncoating still express mature cathepsin L, a lysosomal protease required for virion disassembly in murine L929 cells. This finding suggests that factors in addition to cathepsin L are required for efficient intracellular proteolysis of reovirus virions. Our results demonstrate that virion uncoating is a critical determinant of reovirus cellular host range and that many cells which otherwise support productive reovirus infection cannot efficiently mediate this essential early step in the virus life cycle.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12097555      PMCID: PMC136394          DOI: 10.1128/jvi.76.15.7430-7443.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  75 in total

1.  Junction adhesion molecule is a receptor for reovirus.

Authors:  E S Barton; J C Forrest; J L Connolly; J D Chappell; Y Liu; F J Schnell; A Nusrat; C A Parkos; T S Dermody
Journal:  Cell       Date:  2001-02-09       Impact factor: 41.582

2.  Oncolytic reovirus against ovarian and colon cancer.

Authors:  Kensuke Hirasawa; Sandra G Nishikawa; Kara L Norman; Tommy Alain; Anna Kossakowska; Patrick W K Lee
Journal:  Cancer Res       Date:  2002-03-15       Impact factor: 12.701

3.  Reovirus oncolysis of human breast cancer.

Authors:  Kara L Norman; Matthew C Coffey; Kensuke Hirasawa; Douglas J Demetrick; Sandra G Nishikawa; Lisa M DiFrancesco; James E Strong; Patrick W K Lee
Journal:  Hum Gene Ther       Date:  2002-03-20       Impact factor: 5.695

4.  Effects of pancreatin on the growth of reovirus.

Authors:  C Wallis; J L Melnick; F Rapp
Journal:  J Bacteriol       Date:  1966-07       Impact factor: 3.490

5.  Fate of parental reovirus in infected cell.

Authors:  C T Chang; H J Zweerink
Journal:  Virology       Date:  1971-12       Impact factor: 3.616

6.  Trypsin enhancement of rotavirus infectivity: mechanism of enhancement.

Authors:  S M Clark; J R Roth; M L Clark; B B Barnett; R S Spendlove
Journal:  J Virol       Date:  1981-09       Impact factor: 5.103

7.  Reovirus: evidence for a second step in the intracellular uncoating and transcriptase activation process.

Authors:  J Borsa; M D Sargent; P A Lievaart; T P Copps
Journal:  Virology       Date:  1981-05       Impact factor: 3.616

8.  Protein sigma 1 is the reovirus cell attachment protein.

Authors:  P W Lee; E C Hayes; W K Joklik
Journal:  Virology       Date:  1981-01-15       Impact factor: 3.616

9.  Rotavirus infection induces cytoskeleton disorganization in human intestinal epithelial cells: implication of an increase in intracellular calcium concentration.

Authors:  J P Brunet; N Jourdan; J Cotte-Laffitte; C Linxe; M Géniteau-Legendre; A Servin; A M Quéro
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

10.  Role of the host cell in persistent viral infection: coevolution of L cells and reovoirus during persistent infection.

Authors:  R Ahmed; W M Canning; R S Kauffman; A H Sharpe; J V Hallum; B N Fields
Journal:  Cell       Date:  1981-08       Impact factor: 41.582

View more
  30 in total

1.  Impact of host proteases on reovirus infection in the respiratory tract.

Authors:  Rachel M Nygaard; Joseph W Golden; Leslie A Schiff
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  Reovirus induces and benefits from an integrated cellular stress response.

Authors:  Jennifer A Smith; Stephen C Schmechel; Arvind Raghavan; Michelle Abelson; Cavan Reilly; Michael G Katze; Randal J Kaufman; Paul R Bohjanen; Leslie A Schiff
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

3.  Conformational changes required for reovirus cell entry are sensitive to pH.

Authors:  Deepti Thete; Pranav Danthi
Journal:  Virology       Date:  2015-05-22       Impact factor: 3.616

4.  Activity levels of cathepsins B and L in tumor cells are a biomarker for efficacy of reovirus-mediated tumor cell killing.

Authors:  Y Terasawa; T Hotani; Y Katayama; M Tachibana; H Mizuguchi; F Sakurai
Journal:  Cancer Gene Ther       Date:  2015-01-30       Impact factor: 5.987

5.  Reovirus σ1 Conformational Flexibility Modulates the Efficiency of Host Cell Attachment.

Authors:  Julia R Diller; Sean R Halloran; Melanie Koehler; Rita Dos Santos Natividade; David Alsteens; Thilo Stehle; Terence S Dermody; Kristen M Ogden
Journal:  J Virol       Date:  2020-11-09       Impact factor: 5.103

6.  Synergistic antitumor activity of oncolytic reovirus and chemotherapeutic agents in non-small cell lung cancer cells.

Authors:  Shizuko Sei; Jodie K Mussio; Quan-en Yang; Kunio Nagashima; Ralph E Parchment; Matthew C Coffey; Robert H Shoemaker; Joseph E Tomaszewski
Journal:  Mol Cancer       Date:  2009-07-14       Impact factor: 27.401

7.  Bid regulates the pathogenesis of neurotropic reovirus.

Authors:  Pranav Danthi; Andrea J Pruijssers; Angela K Berger; Geoffrey H Holm; Sandra S Zinkel; Terence S Dermody
Journal:  PLoS Pathog       Date:  2010-07-01       Impact factor: 6.823

8.  Cryptococcal cell morphology affects host cell interactions and pathogenicity.

Authors:  Laura H Okagaki; Anna K Strain; Judith N Nielsen; Caroline Charlier; Nicholas J Baltes; Fabrice Chrétien; Joseph Heitman; Françoise Dromer; Kirsten Nielsen
Journal:  PLoS Pathog       Date:  2010-06-17       Impact factor: 6.823

9.  Insulin degrading enzyme induces a conformational change in varicella-zoster virus gE, and enhances virus infectivity and stability.

Authors:  Qingxue Li; Mir A Ali; Kening Wang; Dean Sayre; Frederick G Hamel; Elizabeth R Fischer; Robert G Bennett; Jeffrey I Cohen
Journal:  PLoS One       Date:  2010-06-25       Impact factor: 3.240

10.  Reovirus oncolysis: the Ras/RalGEF/p38 pathway dictates host cell permissiveness to reovirus infection.

Authors:  Kara L Norman; Kensuke Hirasawa; An-Dao Yang; Michael A Shields; Patrick W K Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.